
Cathlyse 18mg Injection
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Reteplase (18mg)
Overview Cathlyse 18mg Injection
Thrombolytic agent, Cathlyse 18mg Injection, rapidly breaks down blood clots obstructing blood vessels. Its primary application is in acute myocardial infarction (heart attack) treatment, restoring blood flow to ischemic tissue and preventing further damage. Administered intravenously by a physician immediately upon presentation of heart attack symptoms, the injection requires close monitoring of vital signs, including respiration, blood pressure, and oxygen saturation. Concomitant anticoagulant therapy may be implemented. Increased bleeding risk necessitates caution with sharp objects. Potential side effects encompass nausea, vomiting, hypotension, and injection site hemorrhage. Strict application criteria exist, precluding use in patients with recent head trauma, neurosurgery, or active bleeding. Comprehensive medical history review is mandatory prior to administration by qualified medical personnel due to potential contraindications.
Primary Ingredients of Cathlyse 18mg Injection
No text provided. Please provide the text you want me to rewrite.
Uses of Cathlyse 18mg Injection
Myocardial infarction
Major Benefits of Cathlyse 18mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cathlyse 18mg Injection:
- Bleeding disorder
- Nausea
- Vomiting
- Decreased blood pressure
- Injection site bleeding
How to use Cathlyse 18mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Cathlyse 18mg Injection works:
Thrombolytic agent Cathlyse Injection (18mg) dissolves dangerous blood clots within blood vessels. This action restores blood flow to compromised tissues, preventing further damage and improving patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Cathlyse 18mg Injection is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cathlyse 18mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The administration of Cathlyse 18mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingNOT RELEVANT
Irrelevant; Cathlyse 18mg Injection is administered solely in a hospital setting.
KidneyCAUTION
Exercise caution when administering Cathlyse 18mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Cathlyse 18mg Injection is contraindicated in patients exhibiting severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Cathlyse 18mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Cathlyse 18mg Injection is contraindicated in individuals with severe renal dysfunction.
What if you forget to take Cathlyse 18mg Injection :
NA
Facts to Know About Cathlyse 18mg Injection
| Label | Value |
|---|---|
| Type of Compound | Organic Compounds with Carboxyl Groups |
| Potential for Dependence | None. |
| Medication Classification | HEART |
| Mechanism of Action | Clot-busting drugs: Plasminogen activators |
